Vicarious Surgical (RBOTW) Capital Expenditures (2020 - 2025)
Vicarious Surgical (RBOTW) reported Capital Expenditures of $117000.0 for Q3 2025, up 477.42% year-over-year from $20262.6 in Q3 2024, and up 2240.0% quarter-over-quarter from $5000.0 in Q1 2025.
Vicarious Surgical (RBOTW) Capital Expenditures (2020 - 2025) Analysis & Trends
Vicarious Surgical (RBOTW) has 6 years of Capital Expenditures data on file, last reported at $117000.0 in Q3 2025.
- Capital Expenditures for Q3 2025 came in at $117000.0, up 477.42% year-over-year; the trailing twelve-month figure through Sep 2025 was $317000.0 (down 69.01% YoY), and the FY2024 annual result was $180000.0, down 89.22% from the prior year.
- Capital Expenditures grew to $117000.0 in Q3 2025 per RBOTW's latest filing, from $5000.0 in the prior quarter.
- Over five years, Capital Expenditures peaked at $2.0 million in Q1 2022 and troughed at -$31000.0 in Q3 2024.
- A 5-year average of $478500.0 and a median of $201500.0 in 2023 frame the typical range for Capital Expenditures.
- The sharpest annual moves came in 2022 and 2024: Capital Expenditures surged 1479.69% in 2022, then slumped 126.27% in 2024.
- A 5-year view of Capital Expenditures shows it stood at $867000.0 in 2021, then advanced by 14.42% to $992000.0 in 2022, then advanced by 4.64% to $1.0 million in 2023, then slumped by 81.21% to $195000.0 in 2024, then plunged by 40.0% to $117000.0 in 2025.
- Business Quant data shows RBOTW's Capital Expenditures at $117000.0 in Q3 2025, $5000.0 in Q1 2025, and $195000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 399.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 166.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 444.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 177.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 64.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -85.46 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 76.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 86.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 90.20 Mn |
| 10 | Vicarious Surgical | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 117,000.00 |
| Sep 30, 2025 | 117,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 195,000.00 |
| Dec 31, 2024 | 195,000.00 |
| Sep 30, 2024 | -31,000.00 |
| Sep 30, 2024 | -31,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Jun 30, 2024 | 6,000.00 |
| Mar 31, 2024 | 10,000.00 |
| Mar 31, 2024 | 10,000.00 |
| Dec 31, 2023 | 1.04 Mn |
| Dec 31, 2023 | 1.04 Mn |
| Sep 30, 2023 | 118,000.00 |
| Sep 30, 2023 | 118,000.00 |
| Jun 30, 2023 | 208,000.00 |
| Jun 30, 2023 | 208,000.00 |
| Mar 31, 2023 | 306,000.00 |
| Mar 31, 2023 | 306,000.00 |